Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q2 2026 investor letter. A copy of the letter is available to download here. In Q2 2026, the Micro Opportunities strategy underperformed the Russell Microcap Index, despite a positive absolute result. The benchmark performed well during a speculative period for micro caps. Over the past twelve months, the strategy has lagged behind the index. Industrials was the best-performing sector while Information Technology lagged. An accelerating artificial intelligence buildout and a persistent geopolitical supply shock drove the market in the quarter. While the micro-cap rally exhibited speculative traits with significant returns in areas avoided by design. The Fund’s focus remains on owning profitable, well-managed small businesses at reasonable prices rather than pursuing fleeting market trends. In addition, please check the Strategy’s top five holdings to know its best picks in 2026.
In its Q2 2026 investor letter, Riverwater Micro Opportunities Strategy highlighted Lifeway Foods, Inc. (NASDAQ:LWAY). Lifeway Foods, Inc. (NASDAQ:LWAY) is a leading producer and marketer probiotic rich dairy products known for its product, drinkable kefir. On July 23, 2026, Lifeway Foods, Inc. (NASDAQ:LWAY) closed at $30.33 per share, reflecting a market capitalization of $463.5 million. Lifeway Foods, Inc. (NASDAQ:LWAY) posted a one-month return of 3.20%, while its shares gained 14.58% over the past 52 weeks.
Riverwater Micro Opportunities Strategy stated the following regarding Lifeway Foods, Inc. (NASDAQ:LWAY) in its Q2 2026 investor update:
“We added Lifeway Foods, Inc. (NASDAQ:LWAY) in April, the dominant U.S. producer of kefir. Lifeway reported record quarterly sales of $63 million, up 37% and driven by volume rather than price, with gross margin expanding meaningfully on favorable milk costs, and a major plant expansion remains on track for completion by year end.
Lifeway Foods (LWAY) is the largest producer and marketer of kefir in the United States. Kefir is a tart, tangy cultured milk rich in probiotics, protein, calcium, and vitamin D, with roots in Eastern Europe dating back generations. Lifeway was the first company to introduce kefir to U.S. consumers on a commercial scale and dominates the market. Lifeway has an exclusive blend of kefir cultures containing 12 live and active probiotics and its core kefir line offers variations including traditional, organic, grass fed, lactose free, and collagen added. Additionally, Lifeway is extending its brand into adjacent categories, including Probugs kefir pouches for kids, farmer cheese, a high protein and creatine line, a new probiotic butter, and a licensing agreement for probiotic dog kibble under the Open Farm brand…” (Click here to read the full text)
Lifeway Foods, Inc. (NASDAQ:LWAY) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 14 hedge fund portfolios held Lifeway Foods, Inc. (NASDAQ:LWAY) at the end of the first quarter, compared to 17 in the previous quarter. While we acknowledge the risk and potential of Lifeway Foods, Inc. (NASDAQ:LWAY) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Lifeway Foods, Inc. (NASDAQ:LWAY) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In addition, please check out our hedge fund investor letters Q2 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
